{"ID": "DDI-DrugBank.d158.s6.p4", "TEXT1": "It is not currently known whether MAO inhibitors or the metabolite of furazolidone affects amphetamine metabolism.", "LBL": "DDI-mechanism", "DRUGA": ["MAOI antidepressants", "group", "15-34"], "DRUGB": ["amphetamine", "drug", "83-93"]}
{"ID": "DDI-DrugBank.d158.s6.p5", "TEXT1": "MAO inhibitors and MAOI antidepressants slow amphetamine metabolism, as does a metabolite of furazolidone.", "LBL": "DDI-mechanism", "DRUGA": ["furazolidone", "drug", "64-75"], "DRUGB": ["amphetamine", "drug", "83-93"]}
{"ID": "DDI-DrugBank.d158.s10.p0", "TEXT1": "If you're taking antihistamines, be aware that amphetamines may reduce the sedative effect of the antihistamines.", "LBL": "0", "DRUGA": ["Antihistamines", "group", "0-13"], "DRUGB": ["Amphetamines", "group", "16-27"]}
{"ID": "DDI-DrugBank.d158.s10.p1", "TEXT1": "Amphetamines may counteract the sedative effect of antihistamines.", "LBL": "0", "DRUGA": ["Antihistamines", "group", "0-13"], "DRUGB": ["antihistamines", "group", "67-80"]}
{"ID": "DDI-DrugBank.d158.s10.p2", "TEXT1": "It is not recommended to take amphetamines with antihistamines, as the amphetamines may counteract the sedative effect of the antihistamines.", "LBL": "DDI-effect", "DRUGA": ["Amphetamines", "group", "16-27"], "DRUGB": ["antihistamines", "group", "67-80"]}
{"ID": "DDI-DrugBank.d158.s11.p0", "TEXT1": "It is not known whether amphetamines may reduce the effectiveness of antihypertensives in lowering blood pressure.", "LBL": "0", "DRUGA": ["Antihypertensives", "group", "0-16"], "DRUGB": ["Amphetamines", "group", "19-30"]}
{"ID": "DDI-DrugBank.d158.s11.p1", "TEXT1": "Other drugs that lower blood pressure may reduce the effectiveness of amphetamines.", "LBL": "0", "DRUGA": ["Antihypertensives", "group", "0-16"], "DRUGB": ["antihypertensives", "drug", "74-90"]}
{"ID": "DDI-DrugBank.d158.s11.p2", "TEXT1": "If you are taking antihypertensive medication, please be aware that amphetamines may counteract the effects of these drugs.", "LBL": "DDI-effect", "DRUGA": ["Amphetamines", "group", "19-30"], "DRUGB": ["antihypertensives", "drug", "74-90"]}
{"ID": "DDI-DrugBank.d158.s12.p0", "TEXT1": "Chlorpromazine can help to reduce the central stimulant effects of amphetamines by blocking dopamine and norepinephrine receptors. This makes it a possible treatment for amphetamine poisoning.", "LBL": "0", "DRUGA": ["Chlorpromazine", "drug", "0-13"], "DRUGB": ["Chlorpromazine", "drug", "16-29"]}
{"ID": "DDI-DrugBank.d158.s12.p1", "TEXT1": "Chlorpromazine can be used to treat amphetamine poisoning by blocking dopamine and norepinephrine receptors and inhibiting the central stimulant effects of amphetamines.", "LBL": "0", "DRUGA": ["Chlorpromazine", "drug", "0-13"], "DRUGB": ["amphetamines", "group", "126-137"]}
{"ID": "DDI-DrugBank.d158.s12.p2", "TEXT1": "Chlorpromazine may help to reduce the central stimulant effects of amphetamines, by blocking dopamine and norepinephrine receptors. Therefore, it may be useful in treating amphetamine poisoning.", "LBL": "0", "DRUGA": ["Chlorpromazine", "drug", "0-13"], "DRUGB": ["amphetamine", "group", "164-174"]}
{"ID": "DDI-DrugBank.d158.s12.p3", "TEXT1": "Chlorpromazine can help to counteract the central stimulant effects of amphetamines by blocking dopamine and norepinephrine receptors.", "LBL": "DDI-effect", "DRUGA": ["Chlorpromazine", "drug", "16-29"], "DRUGB": ["amphetamines", "group", "126-137"]}
{"ID": "DDI-DrugBank.d158.s12.p4", "TEXT1": "Chlorpromazine works to block dopamine and norepinephrine receptors, which can help to reduce the central stimulant effects of amphetamines. This medication can be used to treat amphetamine poisoning.", "LBL": "0", "DRUGA": ["Chlorpromazine", "drug", "16-29"], "DRUGB": ["amphetamine", "group", "164-174"]}
{"ID": "DDI-DrugBank.d158.s12.p5", "TEXT1": "Chlorpromazine may help to reduce the central stimulant effects of amphetamines by blocking dopamine and norepinephrine receptors. This medication can be used to treat amphetamine poisoning.", "LBL": "0", "DRUGA": ["amphetamines", "group", "126-137"], "DRUGB": ["amphetamine", "group", "164-174"]}
{"ID": "DDI-DrugBank.d158.s13.p0", "TEXT1": "Ethosuximide: Amphetamines may decrease the rate of intestinal absorption of ethosuximide.", "LBL": "0", "DRUGA": ["Ethosuximide", "drug", "0-11"], "DRUGB": ["Amphetamines", "group", "14-25"]}
{"ID": "DDI-DrugBank.d158.s13.p1", "TEXT1": "Ethosuximide: Amphetamines may slow down the intestinal absorption of ethosuximide.", "LBL": "0", "DRUGA": ["Ethosuximide", "drug", "0-11"], "DRUGB": ["ethosuximide", "drug", "62-73"]}
{"ID": "DDI-DrugBank.d158.s13.p2", "TEXT1": "If ethosuximide and amphetamines are used together, the absorption of ethosuximide may be delayed.", "LBL": "DDI-mechanism", "DRUGA": ["Amphetamines", "group", "14-25"], "DRUGB": ["ethosuximide", "drug", "62-73"]}
{"ID": "DDI-DrugBank.d158.s14.p0", "TEXT1": "Haloperidol blocks dopamine receptors, which can inhibit the central stimulant effects of amphetamines.", "LBL": "0", "DRUGA": ["Haloperidol", "drug", "0-10"], "DRUGB": ["Haloperidol", "drug", "13-23"]}
{"ID": "DDI-DrugBank.d158.s14.p1", "TEXT1": "The blocking of dopamine receptors by haloperidol may inhibit the central stimulant effects of amphetamines.", "LBL": "0", "DRUGA": ["Haloperidol", "drug", "0-10"], "DRUGB": ["amphetamines", "group", "101-112"]}
{"ID": "DDI-DrugBank.d158.s14.p2", "TEXT1": "If you take haloperidol, it may block the dopamine receptors and inhibit the central stimulant effects of amphetamines.", "LBL": "DDI-effect", "DRUGA": ["Haloperidol", "drug", "13-23"], "DRUGB": ["amphetamines", "group", "101-112"]}
{"ID": "DDI-DrugBank.d158.s15.p0", "TEXT1": "The anorectic and stimulatory effects of amphetamines may be inhibited by lithium carbonate.", "LBL": "0", "DRUGA": ["Lithium carbonate", "drug", "0-16"], "DRUGB": ["amphetamines", "group", "60-71"]}
{"ID": "DDI-DrugBank.d158.s15.p1", "TEXT1": "It is possible that the anorectic and stimulatory effects of amphetamines may be hindered by lithium carbonate.", "LBL": "0", "DRUGA": ["Lithium carbonate", "drug", "0-16"], "DRUGB": ["lithium carbonate", "drug", "93-109"]}
{"ID": "DDI-DrugBank.d158.s15.p2", "TEXT1": "The concomitant administration of lithium carbonate and amphetamines is not recommended, as the stimulatory effects of amphetamines may be inhibited by lithium carbonate.", "LBL": "DDI-effect", "DRUGA": ["amphetamines", "group", "60-71"], "DRUGB": ["lithium carbonate", "drug", "93-109"]}
{"ID": "DDI-DrugBank.d158.s16.p0", "TEXT1": "Meperidine and amphetamines may enhance each other's effects, so it is best to avoid using them together.", "LBL": "0", "DRUGA": ["Meperidine", "drug", "0-9"], "DRUGB": ["Amphetamines", "group", "12-23"]}
{"ID": "DDI-DrugBank.d158.s16.p1", "TEXT1": "Amphetamines appear to potentiate the analgesic effect of meperidine, though it is not clear how or why this occurs.", "LBL": "0", "DRUGA": ["Meperidine", "drug", "0-9"], "DRUGB": ["meperidine", "drug", "60-69"]}
{"ID": "DDI-DrugBank.d158.s16.p2", "TEXT1": "Meperidine: Amphetamines can enhance the pain-relieving effect of meperidine.", "LBL": "DDI-effect", "DRUGA": ["Amphetamines", "group", "12-23"], "DRUGB": ["meperidine", "drug", "60-69"]}
{"ID": "DDI-DrugBank.d158.s17.p0", "TEXT1": "The use of methenamine therapy alongside amphetamines may reduce the effectiveness of the latter.", "LBL": "0", "DRUGA": ["Methenamine", "drug", "0-10"], "DRUGB": ["amphetamines", "group", "41-52"]}
{"ID": "DDI-DrugBank.d158.s17.p1", "TEXT1": "If you are taking methenamine therapy, please be aware that urinary excretion of amphetamines is increased. Additionally, the efficacy of methenamine therapy is reduced by acidifying agents.", "LBL": "0", "DRUGA": ["Methenamine", "drug", "0-10"], "DRUGB": ["methenamine", "drug", "121-131"]}
{"ID": "DDI-DrugBank.d158.s17.p2", "TEXT1": "Methenamine therapy can interfere with the efficacy of amphetamines by increasing their urinary excretion.", "LBL": "DDI-mechanism", "DRUGA": ["amphetamines", "group", "41-52"], "DRUGB": ["methenamine", "drug", "121-131"]}
{"ID": "DDI-DrugBank.d158.s18.p0", "TEXT1": "Norepinephrine: Amphetamines may enhance the adrenergic effect of norepinephrine.", "LBL": "0", "DRUGA": ["Norepinephrine", "drug", "0-13"], "DRUGB": ["Amphetamines", "group", "16-27"]}
{"ID": "DDI-DrugBank.d158.s18.p1", "TEXT1": "Amphetamines are known to enhance the adrenergic effect of norepinephrine, which may cause increased blood pressure and heart rate.", "LBL": "0", "DRUGA": ["Norepinephrine", "drug", "0-13"], "DRUGB": ["norepinephrine", "drug", "62-75"]}
{"ID": "DDI-DrugBank.d158.s18.p2", "TEXT1": "Norepinephrine and amphetamines may enhance each other's effects.", "LBL": "DDI-effect", "DRUGA": ["Amphetamines", "group", "16-27"], "DRUGB": ["norepinephrine", "drug", "62-75"]}
{"ID": "DDI-DrugBank.d158.s19.p0", "TEXT1": "Amphetamines may delay the absorption of phenobarbital in the intestine.", "LBL": "0", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["Amphetamines", "group", "15-26"]}
{"ID": "DDI-DrugBank.d158.s19.p1", "TEXT1": "Phenobarbital: Amphetamines might delay intestinal absorption of phenobarbital;", "LBL": "0", "DRUGA": ["Phenobarbital", "drug", "0-12"], "DRUGB": ["phenobarbital", "drug", "63-75"]}
{"ID": "DDI-DrugBank.d158.s19.p2", "TEXT1": "There is a possibility that amphetamines may slow down the intestinal absorption of phenobarbital; however, this has not been definitively proven.", "LBL": "DDI-mechanism", "DRUGA": ["Amphetamines", "group", "15-26"], "DRUGB": ["phenobarbital", "drug", "63-75"]}
{"ID": "DDI-DrugBank.d158.s21.p0", "TEXT1": "Taking amphetamines may delay the intestinal absorption of phenytoin.", "LBL": "0", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["Amphetamines", "group", "11-22"]}
{"ID": "DDI-DrugBank.d158.s21.p1", "TEXT1": "If you are taking phenytoin, please be aware that Amphetamines may delay the intestinal absorption of the drug.", "LBL": "0", "DRUGA": ["Phenytoin", "drug", "0-8"], "DRUGB": ["phenytoin", "drug", "59-67"]}
{"ID": "DDI-DrugBank.d158.s21.p2", "TEXT1": "It is possible that amphetamines may delay the intestinal absorption of phenytoin; however, this has not been definitively proven.", "LBL": "DDI-mechanism", "DRUGA": ["Amphetamines", "group", "11-22"], "DRUGB": ["phenytoin", "drug", "59-67"]}
{"ID": "DDI-DrugBank.d158.s23.p0", "TEXT1": "Propoxyphene: In cases of propoxyphene overdosage, amphetamine CNS stimulation may be potentiated and fatal convulsions could occur.", "LBL": "0", "DRUGA": ["Propoxyphene", "drug", "0-11"], "DRUGB": ["propoxyphene", "drug", "26-37"]}
{"ID": "DDI-DrugBank.d158.s23.p1", "TEXT1": "If propoxyphene and amphetamine are used together, the central nervous system stimulation caused by the amphetamine can be potentiated, which may lead to fatal convulsions.", "LBL": "0", "DRUGA": ["Propoxyphene", "drug", "0-11"], "DRUGB": ["amphetamine", "drug", "51-61"]}
{"ID": "DDI-DrugBank.d158.s23.p2", "TEXT1": "In cases of propoxyphene overdosage, CNS stimulation from amphetamine is increased and can lead to fatal convulsions.", "LBL": "DDI-effect", "DRUGA": ["propoxyphene", "drug", "26-37"], "DRUGB": ["amphetamine", "drug", "51-61"]}
{"ID": "DDI-DrugBank.d158.s24.p0", "TEXT1": "Veratrum alkaloids: Amphetamines may reduce the hypotensive effect of veratrum alkaloids.", "LBL": "0", "DRUGA": ["Veratrum alkaloids", "group", "0-17"], "DRUGB": ["Amphetamines", "group", "20-31"]}
{"ID": "DDI-DrugBank.d158.s24.p2", "TEXT1": "It is not known for certain whether amphetamines inhibit the hypotensive effect of veratrum alkaloids due to the presence of veratrum alkaloids or hyperuricemia in these patients.", "LBL": "DDI-effect", "DRUGA": ["Amphetamines", "group", "20-31"], "DRUGB": ["veratrum alkaloids", "group", "67-84"]}
{"ID": "DDI-DrugBank.d309.s0.p0", "TEXT1": "If antihistamines are taken together with other CNS depressants such as barbiturates, tranquilizers, and alcohol, additive CNS depression may occur.", "LBL": "DDI-effect", "DRUGA": ["antihistamines", "group", "39-52"], "DRUGB": ["CNS depressants", "group", "96-110"]}
{"ID": "DDI-DrugBank.d309.s0.p1", "TEXT1": "CNS depression may occur when antihistamines are administered together with other CNS depressants, including barbiturates, tranquilizers, and alcohol.", "LBL": "DDI-effect", "DRUGA": ["antihistamines", "group", "39-52"], "DRUGB": ["barbiturates", "group", "122-133"]}
{"ID": "DDI-DrugBank.d309.s0.p2", "TEXT1": "Concurrent use of antihistamines with other CNS depressants such as barbiturates, tranquilizers, and alcohol may result in additive CNS depression.", "LBL": "DDI-effect", "DRUGA": ["antihistamines", "group", "39-52"], "DRUGB": ["tranquilizers", "group", "136-148"]}
{"ID": "DDI-DrugBank.d309.s0.p3", "TEXT1": "Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.", "LBL": "DDI-effect", "DRUGA": ["antihistamines", "group", "39-52"], "DRUGB": ["alcohol", "drug", "155-161"]}
{"ID": "DDI-DrugBank.d529.s6.p0", "TEXT1": "It is not recommended to use flurbiprofen and aspirin concurrently.", "LBL": "DDI-advise", "DRUGA": ["flurbiprofen", "drug", "18-29"], "DRUGB": ["aspirin", "brand", "35-41"]}
{"ID": "DDI-DrugBank.d529.s11.p0", "TEXT1": "If you are taking both flurbiprofen and a beta-blocker, it is recommended that you be monitored closely to make sure that your blood pressure stays at a satisfactory level.", "LBL": "DDI-advise", "DRUGA": ["flurbiprofen", "drug", "21-32"], "DRUGB": ["beta-blocker", "group", "40-51"]}
{"ID": "DDI-DrugBank.d511.s0.p0", "TEXT1": "A possible drug interaction of FOSCAVIR and intravenous pentamidine has been described.", "LBL": "DDI-int", "DRUGA": ["FOSCAVIR", "brand", "31-38"], "DRUGB": ["pentamidine", "drug", "56-66"]}
